These clinical observations, however, not only indicate that the TDP-43 proteinopathies vary but also suggests that although TDP-43 mutations clearly contribute to the disease, other genetic and/or environmental factors likely play a significant role in disease onset and progression. The gene discussed is TARDBP; the disease is proteostasis deficiencies.